Live Breaking News & Updates on Clinical Experiences Under Right

ELK CITY, Idaho, September 11, 2023 Therapeutic Solutions International, Inc. (TSOI), announced today the development of a new therapeutic approach for treatment of Frontotemporal Dementia, by combining the activation of endogenous anti-inflammatory cells in the nervous system, together with regenerative cell intervention in the form of stem cell therapy, and molecules capable of activating endogenous stem cells already present in the patient. ....

United States , Timothyg Dixon , Thomas Ichim , Campbell Neurosciences , James Veltmeyer , Therapeutic Solutions International , Company Leverages , Board Member Of The Company , Veltmeyer Institute , Therapeutic Solutions International Inc , New Drug Disease Filing , Clinical Experiences Under Right , Create Multidisciplinary Protocol , Address Common , Frontotemporal Dementia , Chief Medical Officer , Board Member , Solutions International , Chief Executive Officer , Frontotemporal Dementia , The Company , Therapeutic Solutions International , Stem Cell Therapy , Therapeutic Solutions , Dr James Veltmeyer , Chief Medical Officer ,